#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant peritoneal neoplasm Marginal zone lymphoma refractory Thrombotic microangiopathy Arrhythmia Synovial sarcoma metastatic Fallopian tube cancer Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Immunodeficiency congenital Ureteric cancer Immune-mediated myasthenia gravis Erythema multiforme Small cell lung cancer extensive stage Blastic plasmacytoid dendritic cell neoplasia MELAS syndrome Sarcoma More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia Marfan’s syndrome – Trials in Disease X-linked lymphoproliferative syndrome – Diagnostics Leiomyosarcoma recurrent – Diagnostics Marfan’s syndrome – Treatment Fragile X syndrome Haemophilia B without inhibitors – Basic Information Advanced systemic mastocytosis – Trials in Disease Alport’s syndrome – Diagnostics Usher’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vindesine Sulfate GSK4418959A Ceralasertib Formoterol Fumarate Dihydrate Phenprocoumon Glepaglutide Camlipixant Cpft Trifluoroacetate FG001 SODIUM DIHYDROGEN PHOSPHATE RO7837195 Acetylsalicylic Acid Ph. Eur. Perindopril Arginine Fenfluramine Hydrochloride Df1001 Lithium Sulphate, Anhydrous Dorocubicel Olaparib Betula Verrucosa (108) Dabrafenib Mesylate More therapies…

    Learn about Your Condition

    Seasonal allergy Erectile dysfunction Laryngeal leukoplakia Connective tissue disorder Fibrosarcoma metastatic Hip fracture Vulvar dysplasia Peripheral artery restenosis Ocular melanoma Muscle injury Laparotomy Oesophagogastroscopy Epidermolysis bullosa Acne Salivary gland cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications

    Recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Bulgaria Croatia Czechia France Germany Hungary +3

  • Study of psilocybin compared to personalized rTMS treatment in adults with treatment-resistant depression

    Recruiting

    2 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Italy

  • Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Linvoseltamab
    • Daratumumab
    • Dexamethasone
    Austria Belgium Croatia Czechia Denmark Estonia +10

  • Long-term safety and effectiveness study of APG777 injection in patients with moderate-to-severe atopic dermatitis who previously received APG777 treatment

    Recruiting

    2 1
    Investigated Drugs:
    • Apg777
    Czechia France Germany Hungary Poland Spain

  • Comparison of Gentamicin with Narrow-Spectrum Antibiotics versus Broad-Spectrum Antibiotics in Adult Patients with Early Sepsis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Benzathine Benzylpenicillin
    • BENZYLPENICILLIN POTASSIUM
    • BENZYLPENICILLIN PROCAINE
    Norway

  • Study of BMS-986504 for patients with advanced or metastatic non-small cell lung cancer with homozygous MTAP deletion who have previously received treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • 2-[4-[4-(AMINOMETHYL)-1-OXO-2H-PHTHALAZIN-6-YL]-2-METHYLPYRAZOL-3-YL]-4-CHLORO-6-CYCLOPROPYLOXY-3-FLUOROBENZONITRILE
    France Germany Italy Poland Romania Spain +1
Previous Page
1 … 141 142 143 144 145 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!